Italiano Antoine։ Where T Cells Are Located Matters for Cancer Immunotherapy
Italiano Antoine/LinkedIn

Italiano Antoine։ Where T Cells Are Located Matters for Cancer Immunotherapy

Italiano Antoine, Head of Precision Medicine at Gustave Roussy, shared on LinkedIn:

“Where T cells are located matters for cancer immunotherapy.

Pleased to share our new study in Signal Transduction and Targeted Therapy, exploring immune exclusion in advanced non-small cell lung cancer.

In some tumors, CD8+ T cells are present but remain in the surrounding stroma, with limited access to tumor nests.

We asked which tumor and stromal features accompany this spatial pattern and how it relates to treatment outcomes.

We assessed immune architecture in 261 patients treated with immune checkpoint inhibitors, with or without chemotherapy: a discovery cohort of 144 patients and a non-overlapping internal validation cohort of 117.

In the discovery cohort, objective response rates were:

  • 58% in immune-infiltrated tumors
  • 38% in immune-excluded tumors
  • 20% in immune-desert tumors.

Integrating spatial transcriptomics, bulk gene-expression profiling and multiplex imaging in tumor subsets, we identified three features associated with immune exclusion:

  • Reduced tumor antigen-presentation programs, including HLA class I and TAP1.
  • Myofibroblastic cancer-associated fibroblasts and collagen-rich architecture close to tumor nests.
  • Reduced metabolic activation programs in CD8-enriched regions, without a marked increase in the canonical exhaustion markers assessed.

These findings connect tumor immune visibility, stromal organization and T-cell positioning within the same clinical framework. They support further evaluation of spatial immune contexture as a complementary biomarker and provide a rationale for investigating strategies that address both tumor recognition and immune access.

External and functional validation will be essential.

Many thanks to Jean-Philippe Guegan, Alban Bessede and all our colleagues at Explicyte, Institut Bergonié, Gustave Roussy, Université Paris-Saclay.

Title: Spatial transcriptomics identifies tumor-intrinsic and stromal programs associated with immune exclusion in NSCLC

Authors: Jean-Philippe Guegan, Benjamin Bonhomme, Florent Peyraud, Christophe Rey, Sophie Cousin, Mihaela Aldea, Fabrice Barlesi, Benjamin Besse, David Planchard, Natalie Karpinich, Jaegil Kim, Racha Cheikh, Sapna Yadavilli, Alban Bessede, Antoine Italiano

Read the article

You can also read: CAR T-Cell Therapy Recovery Time: Timeline After Infusion and Follow-Up.

OncoDaily